[Pharmacoeconomic Comparison Between Dupilumab and Tralokinumab for the Treatment of Atopic Dermatitis in Italy: A Cost-per-Responder Analysis]. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 26, n. 1, 2025. DOI: 10.7175/fe.v26i1.1571. Disponível em: https://journals.seedstm.com/index.php/FE/article/view/1571. Acesso em: 29 oct. 2025.